Associated Neurologists of Southern CT, PC

Fairfield, Connecticut 06824

0 studies enrolling now · 17 studies all time

What they study most

Acute Migraine, Alzheimer's Disease, Cerebral Palsy, Glioblastoma Multiforme, Leg Spasticity, Migraine Disorders, Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Muscle Spasticity, NSCLC, Nonsmall Cell Lung Cancer, Parkinson's Disease

Studies at this site

• A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease — Running, not enrolling
• Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR) — Completed
• A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis — Completed
• Nativis Voyager for Newly Diagnosed GBM — Completed
• A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) — Completed
• Dysport® Adult Lower Limb Spasticity Study — Completed
• A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT) — Completed
• Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations — Stopped early
• BOTOX® Treatment in Pediatric Lower Limb Spasticity — Completed
• BOTOX® Treatment in Pediatric Upper Limb Spasticity — Completed
• A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke — Stopped early
• DFN-02 Open Label Safety Study in Patients With Acute Migraine — Completed
• Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis — NO_LONGER_AVAILABLE
• A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine — Completed
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) — Completed
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) — Completed
• Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis — Completed